BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25595908)

  • 21. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
    Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
    Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
    Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J
    Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.
    Keld R; Guo B; Downey P; Gulmann C; Ang YS; Sharrocks AD
    Mol Cancer; 2010 Dec; 9():313. PubMed ID: 21143918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.
    Currie SL; Lau DKW; Doane JJ; Whitby FG; Okon M; McIntosh LP; Graves BJ
    Nucleic Acids Res; 2017 Mar; 45(5):2223-2241. PubMed ID: 28161714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion between TMPRSS2 and ETS family members (ERG, ETV1, ETV4) in prostate cancers from northern China.
    Wang JJ; Liu YX; Wang W; Yan W; Zheng YP; Qiao LD; Liu D; Chen S
    Asian Pac J Cancer Prev; 2012; 13(10):4935-8. PubMed ID: 23244085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
    Hermans KG; van der Korput HA; van Marion R; van de Wijngaart DJ; Ziel-van der Made A; Dits NF; Boormans JL; van der Kwast TH; van Dekken H; Bangma CH; Korsten H; Kraaij R; Jenster G; Trapman J
    Cancer Res; 2008 Sep; 68(18):7541-9. PubMed ID: 18794142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
    Ribeiro FR; Paulo P; Costa VL; Barros-Silva JD; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    PLoS One; 2011; 6(7):e22317. PubMed ID: 21814574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
    Gasi D; Trapman J
    Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
    Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM
    Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
    Aytes A; Mitrofanova A; Kinkade CW; Lefebvre C; Lei M; Phelan V; LeKaye HC; Koutcher JA; Cardiff RD; Califano A; Shen MM; Abate-Shen C
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):E3506-15. PubMed ID: 23918374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.
    Paulo P; Ribeiro FR; Santos J; Mesquita D; Almeida M; Barros-Silva JD; Itkonen H; Henrique R; Jerónimo C; Sveen A; Mills IG; Skotheim RI; Lothe RA; Teixeira MR
    Neoplasia; 2012 Jul; 14(7):600-11. PubMed ID: 22904677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.
    Oh S; Shin S; Lightfoot SA; Janknecht R
    Cancer Res; 2013 Aug; 73(16):5110-9. PubMed ID: 23774214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.
    Segalés L; Juanpere N; Lorenzo M; Albero-González R; Fumadó L; Cecchini L; Bellmunt J; Lloreta-Trull J; Hernández-Llodrà S
    Virchows Arch; 2019 Oct; 475(4):457-466. PubMed ID: 31016435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells.
    Hollenhorst PC; Paul L; Ferris MW; Graves BJ
    Genes Cancer; 2011 Jan; 1(10):1044-1052. PubMed ID: 21373373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylogenetically interrelated ETS genes, ETV1, ERM and E1A-F locate on different chromosomes.
    Jeon IS; Shapiro DN
    J Korean Med Sci; 1998 Aug; 13(4):355-60. PubMed ID: 9741538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
    Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
    PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.